37098-74-1

Basic information

• Product Name: 3-(BENZYLOXY)PIPERIDINE
• Synonyms: 3-(BENZYLOXY)PIPERIDINE;3-(benzyloxy)piperidine(SALTDATA: HCl);3-(benzyloxy)piperidine 1HCl
• CAS NO: 37098-74-1
• Molecular Formula: C12H17NO
• Molecular Weight: 191.26948
• Mol File: 37098-74-1.mol

Chemical Properties

• Boiling Point: 288.3°C at 760 mmHg
• Flash Point: 116.7°C
• Appearance: /
• Density: 1.03g/cm³
• Vapor Pressure: 0.00236mmHg at 25°C
• Refractive Index: 1.539
• PKA: 9.37±0.10(Predicted)
• CAS DataBase Reference: 3-(BENZYLOXY)PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(BENZYLOXY)PIPERIDINE(37098-74-1)
• EPA Substance Registry System: 3-(BENZYLOXY)PIPERIDINE(37098-74-1)

Safety Data

• Hazardous Substances Data: 37098-74-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-(Benzyloxy)piperidine is utilized as a key building block in organic synthesis for the preparation of a wide range of pharmaceuticals. Its unique structure and functional group contribute to the development of new drug molecules with improved therapeutic effects.
Used as Antipsychotic and Antidepressant Agent:
In the field of psychopharmacology, 3-(Benzyloxy)piperidine is employed as a potential antipsychotic and antidepressant agent. Its pharmacological properties have been studied for their ability to modulate neurotransmitter systems, offering new avenues for the treatment of mental health disorders.
Used in Neurodegenerative Disease Treatment:
3-(Benzyloxy)piperidine has been investigated for its potential application in the treatment of neurodegenerative diseases. Its biological activity suggests that it may have neuroprotective effects, offering hope for the development of new therapies to combat conditions such as Alzheimer's and Parkinson's diseases.
Used as Pain-Relief Medication:
In the realm of analgesics, 3-(Benzyloxy)piperidine has been explored for its potential as a pain-relief medication. Its pharmacological properties indicate that it may effectively target pain pathways, providing an alternative to existing pain management options.

InChI:InChI=1/C12H17NO/c1-2-5-11(6-3-1)10-14-12-7-4-8-13-9-12/h1-3,5-6,12-13H,4,7-10H2

Upstream product

• 76509-17-6 3-benzyloxypyridine 

Relevant articles and documents

B(C6F5)3-Catalyzed Cascade Reduction of Pyridines

B(C6F5)3 has been found to be an effective catalyst for reduction of pyridines and other electron-deficient N-heteroarenes with hydrosilanes (or hydroboranes) and amines as the reducing reagents. The success of this development hinges upon the realization of a cascade process of dearomative hydrosilylation (or hydroboration) and transfer hydrogenation. The broad functional-group tolerance (e.g. ketone, ester, unactivated olefins, nitro, nitrile, heterocycles, etc.) implies high practical utility.

Sulfamylbenzoic acids

Certain mono- and disubstituted-5-sulfamylbenzoic acids, many of which are novel, and their use in lowering blood lipid levels in mammals.